BIO-PATH Holdings Amends Bylaws, Modifies Security Holder Rights

TL;DR

**BIO-PATH Holdings just changed its bylaws and security holder rights, watch for details on what it means for your shares!**

AI Summary

BIO-PATH HOLDINGS, INC. filed an 8-K on February 23, 2024, reporting an event that occurred on February 21, 2024. The filing indicates material modifications to the rights of security holders and amendments to its Articles of Incorporation or Bylaws. The company, based in Bellaire, Texas, operates in pharmaceutical preparations.

Why It Matters

This filing signals potential changes in corporate governance and shareholder influence, which could impact investor confidence and the company's operational flexibility.

Risk Assessment

Risk Level: medium — Changes to security holder rights and bylaws can significantly alter investor influence and company control, introducing uncertainty.

Key Players & Entities

• BIO-PATH HOLDINGS, INC. (company) — registrant
• February 21, 2024 (date) — date of earliest event reported
• February 23, 2024 (date) — filed as of date
• Delaware (company) — state of incorporation
• Bellaire, Texas (company) — business address location

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M

Filing Documents

• bpth-20240221x8k.htm (8-K) — 42KB
• bpth-20240221xex3d1.htm (EX-3.1) — 13KB
• bpth-20240221xex99d1.htm (EX-99.1) — 13KB
• bpth-20240221xex99d1001.jpg (GRAPHIC) — 13KB
• 0001558370-24-001573.txt ( ) — 216KB
• bpth-20240221.xsd (EX-101.SCH) — 3KB
• bpth-20240221_lab.xml (EX-101.LAB) — 16KB
• bpth-20240221_pre.xml (EX-101.PRE) — 10KB
• bpth-20240221x8k_htm.xml (XML) — 5KB

03 Material Modification to Rights of Security Holders

Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.

03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 22, 2024, Bio-Path Holdings, Inc. (the "Company") filed a Certificate of Amendment (the "Amendment") to the Company's Certificate of Incorporation with the Delaware Secretary of State to effect a reverse stock split of the Company's Common Stock, par value $0.001 (the "Common Stock") at a ratio of one-for-twenty, effective at 5:30 p.m. Eastern Time on February 22, 2024 (the "Reverse Stock Split") . Upon the effectiveness of the Reverse Stock Split, every twenty shares of Common Stock were automatically combined into one share of Common Stock. No fractional shares of common stock will be issued in connection with the Reverse Stock Split. If as a result of the Reverse Stock Split, a stockholder of record would otherwise hold a fractional share, the stockholder will receive one whole share in lieu of the issuance of any fractional share. The Reverse Stock Split will not change the par value of the Common Stock or modify the rights or preferences of the Common Stock. The Company anticipates that the Reverse Stock Split will reduce the number of shares of the Company's Common Stock issued and outstanding from 12,352,664 to approximately 617,833 shares. All outstanding securities entitling their holders to purchase shares of Common Stock or acquire shares of Common Stock, including stock options and warrants, will be adjusted as a result of the Reverse Stock Split, as required by the terms of those securities. The Company's common stock will begin trading on the Nasdaq Stock Market on a post-Reverse Stock Split basis under the Company's existing trading symbol "BPTH" when the market opens on February 23, 2024 . The CUSIP number for the Company's Common Stock post-Reverse Stock Split is 09057N409. The foregoing description does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment which is attached hereto as Exhibit 3.1

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On February 21, 2024, the Company issued a press release titled, "Bio-Path Holdings Announces 1-for-20 Reverse Stock Split." A copy of the press release is attached hereto as Exhibit 99.1.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 3.1 Certificate of Amendment to Certificate of Incorporation dated effective February 22, 2024. 99.1 Press release dated February 21, 2024. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: February 23, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR